dostęp otwarty
Tom 9, Nr 1 (2023)
Inne materiały uzgodnione z Redakcją
Opublikowany online: 2023-05-17
Pobierz cytowanie
Nadciśnienie tętnicze u chorego z zespołem metabolicznym — proste rozwiązania w praktyce
12, , 1
Nadciśnienie Tętnicze w Praktyce 2023;9(1):26-33.
Afiliacje- Klinika Nadciśnienia Tętniczego, Narodowy Instytut Kardiologii, Warszawa, Polska
- Samodzielna Poradnia Lipidowa, Narodowy Instytut Kardiologii
dostęp otwarty
Tom 9, Nr 1 (2023)
Artykuł redakcyjny
Opublikowany online: 2023-05-17
Streszczenie
Brak
Streszczenie
Brak
Pobierz cytowanie
Informacje o artykuleTytuł
Nadciśnienie tętnicze u chorego z zespołem metabolicznym — proste rozwiązania w praktyce
Czasopismo
Nadciśnienie Tętnicze w Praktyce
Numer
Typ artykułu
Inne materiały uzgodnione z Redakcją
Strony
26-33
Opublikowany online
2023-05-17
Wyświetlenia strony
285
Wyświetlenia/pobrania artykułu
422
Rekord bibliograficzny
Nadciśnienie Tętnicze w Praktyce 2023;9(1):26-33.
Autorzy
Piotr Dobrowolski
Andrzej Januszewicz
Aleksander Prejbisz
Referencje (23)- Dobrowolski P, Prejbisz A, Kuryłowicz A, et al. Metabolic syndrome — a new definition and management guidelines: A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, "Club 30" Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons. Arch Med Sci. 2022; 18(5): 1133–1156.
- Messerli FH, Burnier M. Cardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial? Eur Heart J. 2019; 40(22): 1787–1789.
- Hill A. The Environment and Disease: Association or Causation? Proc R Soc Med. 2016; 58(5): 295–300.
- Hall JE, do Carmo JM, da Silva AA, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015; 116(6): 991–1006.
- Hall ME, Cohen JB, Ard JD, et al. American Heart Association Council on Hypertension; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; and Stroke Council. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2021; 78(5): e38–e50.
- Sundström J, Lind L, Lampa E, et al. Weight gain and blood pressure. J Hypertens. 2020; 38(3): 387–394.
- Lambert EA, Esler MD, Schlaich MP, et al. Obesity-Associated Organ Damage and Sympathetic Nervous Activity. Hypertension. 2019; 73(6): 1150–1159.
- Witteman JC, Willett WC, Stampfer MJ, et al. A prospective study of nutritional factors and hypertension among US women. Circulation. 1989; 80(5): 1320–1327.
- Wilding JPH, Batterham RL, Calanna S, et al. STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021; 384(11): 989–1002.
- Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation. 2018; 137(11): 1132–1142.
- Januszewicz A, Mulatero P, Dobrowolski P, et al. Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022; 80(15): 1480–1497.
- Dézsi CA, Glezer M, Karpov Y, et al. Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies. Adv Ther. 2021; 38(1): 479–494.
- Glezer MG. FORSAGE Investigators. Antihypertensive Effectiveness of Perindopril Arginine and Indapamide Single-Pill Combination According to Body Mass Index: Findings from the FORSAGE Study. Cardiol Ther. 2020; 9(1): 139–152.
- Tykarski A, Filipiak KJ, Januszewicz A, et al. Zasady postępowania w nadciśnieniu tętniczym — 2019 rok. Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Nadciśnienie Tętnicze w Praktyce. 2019; 5(1): 1–86.
- Patel A. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007; 370(9590): 829–840.
- Dézsi CA, Glezer M, Karpov Y, et al. Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies. Adv Ther. 2021; 38(1): 479–494.
- Weber MA, Jamerson K, Bakris GL, et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet. 2013; 381(9866): 537–545.
- Rezaiefar P, Pottie K. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358(9287): 1033–1041.
- Czernichow S, Ninomiya T, Huxley R, et al. Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial. Hypertension. 2010; 55(5): 1193–1198.
- Tóth K. PIANIST Investigators. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients). Am J Cardiovasc Drugs. 2014; 14(2): 137–145.
- Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013; 31(7): 1281–1357.
- Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014; 16(1): 14–26.
- Chalmers J, Arima H, Woodward M, et al. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial. Hypertension. 2014; 63(2): 259–264.
